This study emphasizes the critical role of TLR4 signaling in maintaining the inflammatory microenvironment that promotes leukemic progression, providing a foundation for developing targeted therapies to modulate these pathways in hematologic malignancies [33]. This evidence concerns the gene TLR4 and hematologic disorder.